NFTC
GILD icon

North Forty Two & Co’s Gilead Sciences GILD Stock Holding History

North Forty Two & Co’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$680K Sell
5,380
-25
-0.5% -$3.29K 0.58% 50
2026
Q1 		$753K Hold
5,405
– – 0.7% 39
2025
Q4 		$663K Hold
5,405
– – 0.63% 45
2025
Q3 		$600K Sell
5,405
-800
-13% -$90.9K 0.59% 49
2025
Q2 		$688K Hold
6,205
– – 0.73% 39
2025
Q1 		$695K Hold
6,205
– – 0.77% 41
2024
Q4 		$573K Buy
+6,205
New +$559K 0.66% 45

Other funds holding GILD

Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
TD Asset Management
TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

North Forty Two & Co's GILD Position: Q2 2026 in Review

North Forty Two & Co reduced its Gilead Sciences (GILD) stake by 0.46% in Q2 2026, selling an estimated $3.29K and leaving 5,380 shares worth $680K. The position accounts for 0.58% of the portfolio, ranked #50.

North Forty Two & Co first reported a position in GILD in Q4 2024 and has held it in 7 quarters since. The position peaked at $753K in Q1 2026. 1,154 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • North Forty Two & Co held 5,380 shares of Gilead Sciences worth $680K as of Q2 2026.
  • North Forty Two & Co sold 25 Gilead Sciences shares in Q2 2026, an estimated $3.29K.
  • Gilead Sciences made up 0.58% of North Forty Two & Co's portfolio in Q2 2026, its #50 holding.
  • North Forty Two & Co first reported a position in Gilead Sciences in Q4 2024 and has held it in 7 quarters since.
  • North Forty Two & Co's Gilead Sciences position peaked at $753K in Q1 2026.
  • 1,154 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on North Forty Two & Co's 13F filing for Q2 2026, filed 24 Jul 2026.